Basilea Pharmaceutica AG (BSLN) — Working Capital to Net Assets Ratio

Latest as of December 2025: 158.3%

Basilea Pharmaceutica AG (BSLN) has a Working Capital to Net Assets ratio of 158.3% as of December 2025. Working capital of CHF202.51 Million (current assets of CHF251.73 Million minus current liabilities of CHF49.22 Million) is measured against net assets of CHF127.94 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Basilea Pharmaceutica AG balance sheet quality to measure how much of total assets are equity-financed.

WC/NA Ratio

158.3%
Working Capital / Net Assets

Working Capital

CHF202.51 Million
CHF

Current Assets

CHF251.73 Million
CHF

Current Liabilities

CHF49.22 Million
CHF

Basilea Pharmaceutica AG Working Capital to Net Assets (2002–2025)

This chart shows how Basilea Pharmaceutica AG's Working Capital to Net Assets ratio has evolved across 24 annual periods from 2002 to 2025. As of December 2025, the ratio stands at 158.3%, reflecting working capital of CHF202.51 Million against net assets of CHF127.94 Million CHF. Check Basilea Pharmaceutica AG (BSLN) tangible net worth to evaluate the tangible quality of the company's equity base.

Annual Working Capital to Net Assets for Basilea Pharmaceutica AG (2002–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for Basilea Pharmaceutica AG from 2002 to 2025, covering 24 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Basilea Pharmaceutica AG stock valuation.

Year WC/NA Ratio Working Capital (CHF) Net Assets Current Assets Current Liabilities Change (pp)
2025 158.3% CHF202.51 Million CHF127.94 Million CHF251.73 Million CHF49.22 Million ▼ -58.2 pp
2024 216.5% CHF175.35 Million CHF81.00 Million CHF220.91 Million CHF45.56 Million ▲ +1261.7 pp
2023 -1045.2% CHF104.55 Million CHF-10.00 Million CHF152.15 Million CHF47.59 Million ▼ -560.0 pp
2022 -485.2% CHF100.51 Million CHF-20.71 Million CHF175.36 Million CHF74.85 Million ▼ -371.5 pp
2021 -113.7% CHF66.66 Million CHF-58.61 Million CHF241.07 Million CHF174.41 Million ▲ +56.2 pp
2020 -169.9% CHF173.37 Million CHF-102.05 Million CHF223.53 Million CHF50.16 Million ▼ -52.2 pp
2019 -117.6% CHF109.37 Million CHF-92.96 Million CHF184.86 Million CHF75.49 Million ▲ +194.3 pp
2018 -312.0% CHF208.05 Million CHF-66.69 Million CHF274.74 Million CHF66.68 Million ▲ +203.2 pp
2017 -515.2% CHF213.49 Million CHF-41.44 Million CHF292.98 Million CHF79.49 Million ▲ +43.6 pp
2016 -558.8% CHF195.58 Million CHF-35.00 Million CHF268.49 Million CHF72.91 Million ▼ -2686.1 pp
2015 2127.3% CHF316.03 Million CHF14.86 Million CHF384.87 Million CHF68.84 Million ▲ +1811.6 pp
2014 315.7% CHF182.88 Million CHF57.93 Million CHF244.57 Million CHF61.69 Million ▼ -3.0 pp
2013 318.7% CHF225.86 Million CHF70.87 Million CHF286.17 Million CHF60.31 Million ▲ +32.8 pp
2012 285.8% CHF301.56 Million CHF105.50 Million CHF360.17 Million CHF58.61 Million ▲ +164.9 pp
2011 120.9% CHF185.36 Million CHF153.27 Million CHF219.41 Million CHF34.05 Million ▲ +5.8 pp
2010 115.1% CHF242.02 Million CHF210.24 Million CHF299.57 Million CHF57.55 Million ▼ -39.5 pp
2009 154.6% CHF151.10 Million CHF97.73 Million CHF185.91 Million CHF34.81 Million ▲ +23.8 pp
2008 130.9% CHF261.37 Million CHF199.74 Million CHF304.68 Million CHF43.31 Million ▲ +12.1 pp
2007 118.8% CHF397.99 Million CHF335.10 Million CHF433.94 Million CHF35.95 Million ▼ -19.2 pp
2006 137.9% CHF154.90 Million CHF112.31 Million CHF182.25 Million CHF27.36 Million ▲ +10.9 pp
2005 127.1% CHF213.31 Million CHF167.87 Million CHF232.33 Million CHF19.02 Million ▲ +39.0 pp
2004 88.1% CHF184.63 Million CHF209.60 Million CHF205.80 Million CHF21.16 Million ▲ +9.7 pp
2003 78.4% CHF70.82 Million CHF90.29 Million CHF77.16 Million CHF6.35 Million ▼ -5.7 pp
2002 84.1% CHF105.48 Million CHF125.38 Million CHF119.99 Million CHF14.51 Million
pp = percentage points